GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 23 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $98,000 | -8.4% | 35,419 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $107,000 | -14.4% | 35,419 | -2.8% | 0.00% | 0.0% |
| Q1 2021 | $125,000 | +10.6% | 36,449 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $113,000 | -10.3% | 36,449 | +1.7% | 0.00% | 0.0% |
| Q3 2020 | $126,000 | -25.4% | 35,849 | +1.2% | 0.00% | -50.0% |
| Q2 2020 | $169,000 | +37.4% | 35,419 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $123,000 | -40.0% | 35,419 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $205,000 | +21.3% | 35,419 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $169,000 | -35.0% | 35,419 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $260,000 | -10.0% | 35,419 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $289,000 | +19.4% | 35,419 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $242,000 | – | 35,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|